The EP Registry suite advantage includes enrollment discounts for the EP Device Implant Registry, so you can expand QI activities for your entire EP lab.

Your participation in the AFib Ablation Registry arms you with the tools to effectively track and manage care for your AFib patients.

• Resources and clinical toolkits for quality improvement
  • Unlimited online access to proven quality improvement tools, initiatives and more through the ACC Quality Improvement for Institutions program.
    Learn more at https://cvquality.acc.org.

The AFib Ablation Registry is a data source for the facility metrics associated with Clinical Quality process improvement in ACC's Electrophysiology (EP) Accreditation. ACC accreditations are quality improvement programs that examine the processes, policies, and practices aligned with the care of cardiovascular patients. Through adherence to guideline directed medical therapies, processes associated with procedural care, and tracking of key measures for clinical performance, the path to quality improvement is established to ensure patient safety and reduce variance of care. Learn more about EP Accreditation.

The University of California San Francisco (UCSF) is recruiting participants for the VIBRANT-AF Study. Enrolled AFib Ablation Registry sites are eligible to have their patient's participant in this study that will:

• Identify clinically relevant predictors of effectiveness and complications of atrial fibrillation (AF) procedures in a prospective, multi-center real-world longitudinal study
• Assess how changes in modifiable lifestyle-related exposures influence effectiveness of AF ablation.
• Determine the incidence and predictors of a rare but lethal complication of AF ablation procedures, atrioesophageal fistula.

Potential benefits to sites:

• Repeated and real-time patient-reported outcomes provided directly by participants via the EUREKA mobile app
• Ability to link baseline NCDR data of study patients with longitudinal follow-up data via the EUREKA mobile app
• Data can be connected to various devices, including smartphone (HealthKit) data, personal ECG device data (such as KardiaMobile and Apple Watch data)
• Spanish available, providing the ability to capture the experience of this often under-represented group

What does this involve for my site?

• UCSF has made this as seamless as possible for sites
• Sites that are interested will receive postcards printed with individual study IDs to hand out to their AF ablation patients
• Sites will enter the unique study ID for each patient in the AFib Ablation Registry Research Study Patient ID field
• Interested patients will follow instructions on the postcard to download the EUREKA mobile app
• All study consent and additional data collection will occur via the mobile app

Please email vibrantaf@ucsf.edu or call 415-547-0356 if you are interested or have any questions. Emailing does not obligate you to join but will provide more information about this study. Informational video conference and/or phone call will be available for interested sites.